|
|
Other links at Articles > Gastroenterology |
| 1. |
Treatment-Resistant HCV Patients Respond to Protease Inhibitor-Based Therapy
|
|
|
The investigational protease inhibitor telaprevir (Tibotec and Vertex Pharmaceuticals), added to standard treatment for hepatitis C virus (HCV) infection, produced a sustained virologic response in more than half of patients with treatment-refractory disease, late-breaking clinical trial results show. Reuters Health Information
|
| 4. |
Update on the Treatment of Hepatitis B
|
|
|
Nancy Reau, MD, provides clinical commentary for select feature articles from the literature on issues related to the treatment of hepatitis B.
Medscape Gastroenterology
|
|
|